TrialMedical oncology (Northwood, London, England)2014

Pemetrexed plus dendritic cells as second-line treatment for patients with stage IIIB/IV non-small cell lung cancer who had treatment with TKI.

Rong-Hang Hu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.